Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2011-03-08
2011-03-08
Yu, Misook (Department: 1642)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S141100, C424S143100, C424S277100
Reexamination Certificate
active
07901677
ABSTRACT:
Described is the use of a recombinant antibody comprising a binding site specific for an epitope of the laminin receptor or laminin receptor precursor for the treatment or diagnosis of various cancers, particularly B-CLL. Preferably, this antibody additionally comprises a binding site for at least one particular cell surface antigen.
REFERENCES:
patent: 5637481 (1997-06-01), Ledbetter et al.
patent: 2003/0091569 (2003-05-01), Gerritsen et al.
patent: 2004/0180002 (2004-09-01), Young et al.
patent: 2005/0244899 (2005-11-01), Young et al.
patent: WO 2005/035580 (2005-04-01), None
Belkin et al, Microscropy research and technique, 51: 280-302, 2000.
Mesh word search result for Laminin receptor (2009).
Paul, Fundamental Immunology, 3rd Edition, 1993, pp. 292-295.
Rudikoff et al., Proc. Natl. Acad. Sci. USA 1982 vol. 79: p. 1979.
Casset et al, BBRC 307, 198-205 2003.
Pascalis et al, (The Journal of Immunology vol. 169, 3076-3084, 2002.
Kipriyanov et al , JMB, 293: 41-56, 1999.
Rudikoff et al , Proc Natl Acad Sci USA, 79: 1979, 1982.
International Search Report: PCT/EP2006/003104 mailed Jan. 18, 2007.
Narumi Koh et al.: “Inhibition of Experimental Metastasis of Human Fibrosarcoma Cells by Anti-Recombinant 37-kDa Laminin Binding Protein Antibody”, Japanese Journal of Cancer Research, vol. 90, No. 4, Apr. 1999, pp. 425-431.
Xie M et al,: “Expression and Function of Laminin Receptor in Laryngeal Squamous Cell Carcinoma”, Zhonghua Zhongliu Zazhi—Chinese Journal of Oncology, Zhonghua Yixuehui, Beijing, CN, vol. 26, No. 9, Sep. 23, 2004, pp. 539-542. With English abstract.
Zhonghua Bing Li Xue Za Zhi, Chinese Journal of Pathology, Aug. 1993, vol. 22. No. 4, Aug. 1993, pp. 207-210. With English abstract.
Isemura Mamoru et al.; “Immunohistochemical Detection of the Laminin Receptor Polypeptide, a Putative Precursor of 67 kDa-Laminin Receptor, In Human Lung Cancer”, International Journal of Oncology, vol. 7, No. 1, 1995, pp. 123-126.
Nihon Ky Bu Shikkan Gakkai Zasshi, Dec. 1992, vol. 30 Suppl, Dec. 1992, pp. 92-97.
Viacava P. at al.: “The Spectrum of 67-kD Laminin Receptor Expression in Breast Carcinoma Progression”, Journal of Pathology, Chichester, Sussex, GB, vol. 182, No. 1, May 1997, pp. 36-44.
Martignone S et al.; “Characterization of Two Monoclonal Antibodies Directed against the 67 kDa High Affinity Laminin Receptor and Application for the Study of Breast Carcinoma Progression”, Clinical and Experimental Metastasis, vol. 10, No. 6, 1992, pp. 379-386.
Liotta L A et al,: “Monoclonal Antibodies to the Human Laminin Receptor Recognize Structurally Distinct Sites”, Experimental Cell Research, vol. 156, No. 1, 1985, pp. 117-126.
Chantal Zuber, et al.: “Invasion of Tumorigenic HT1080 Cells Is Impeded by Blocking or Downregulating the 37-kDa/67-kDa Laminin Receptor”, J. Mol, Biol. (2008) 378, pp. 530-539.
Hoffmann Karin
Kipriyanov Sergey
Knackmuss Stefan
Le Gall Fabrice
Little Melvyn
Affimed Therapeutics AG
Howrey LLP
Kung Viola T.
Yao Lei
Yu Misook
LandOfFree
Use of an antibody against the laminin receptor or laminin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of an antibody against the laminin receptor or laminin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of an antibody against the laminin receptor or laminin... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2699086